Found: 5
Select item for more details and to access through your institution.
Analysis of immunohistochemical characteristics and recurrence after complete remission with fertility preservation treatment in patients with endometrial carcinoma and endometrial atypical hyperplasia.
- Published in:
- Archives of Gynecology & Obstetrics, 2023, v. 307, n. 6, p. 2025, doi. 10.1007/s00404-022-06398-3
- By:
- Publication type:
- Article
Targeting Cancer Metabolism Plasticity with JX06 Nanoparticles via Inhibiting PDK1 Combined with Metformin for Endometrial Cancer Patients with Diabetes.
- Published in:
- Advanced Science, 2022, v. 9, n. 8, p. 1, doi. 10.1002/advs.202104472
- By:
- Publication type:
- Article
Maintenance Therapy Can Improve the Oncologic Prognosis and Obstetrical Outcome of Patients With Atypical Endometrial Hyperplasia and Endometrial Cancer After Fertility-Preserving Treatment: A Multicenter Retrospective Study.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.808881
- By:
- Publication type:
- Article
Use of clinicopathological factors to predict prognosis of fertility-sparing treatment for endometrial endometrioid carcinoma and atypical hyperplasia.
- Published in:
- Oncology Letters, 2023, v. 25, n. 2, p. N.PAG
- By:
- Publication type:
- Article
A mechanism study of DUSP1 in inhibiting malignant progression of endometrial carcinoma by regulating ERK/AP-1 axis and dephosphorylation of EPHA2.
- Published in:
- Journal of Cancer, 2023, v. 14, n. 4, p. 634, doi. 10.7150/jca.81069
- By:
- Publication type:
- Article